首页> 美国卫生研究院文献>Transgender Health >Guidance and Ethical Considerations for Undertaking Transgender Health Research and Institutional Review Boards Adjudicating this Research
【2h】

Guidance and Ethical Considerations for Undertaking Transgender Health Research and Institutional Review Boards Adjudicating this Research

机译:进行跨性别健康研究和机构审查委员会对该研究进行评审的指导和道德考虑

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The purpose of this review is to create a set of provisional criteria for Institutional Review Boards (IRBs) to refer to when assessing the ethical orientation of transgender health research proposals. We began by searching for literature on this topic using databases and the reference lists of key articles, resulting in a preliminary set of criteria. We then collaborated to develop the following nine guidelines: (1) Whenever possible, research should be grounded, from inception to dissemination, in a meaningful collaboration with community stakeholders; (2) language and framing of transgender health research should be non-stigmatizing; (3) research should be disseminated back to the community; (4) the diversity of the transgender and gender diverse (TGGD) community should be accurately reflected and sensitively reflected; (5) informed consent must be meaningful, without coercion or undue influence; (6) the protection of participant confidentiality should be paramount; (7) alternative consent procedures should be considered for TGGD minors; (8) research should align with current professional standards that refute conversion, reorientation, or reparative therapy; and (9) IRBs should guard against the temptation to avoid, limit, or delay research on this subject.
机译:此次审查的目的是为机构审查委员会(IRB)创建一套临时标准,以供评估跨性别健康研究建议的伦理取向时参考。我们首先使用数据库和关键文章的参考列表搜索有关此主题的文献,从而得出了一套初步的标准。然后,我们合作制定了以下九项准则:(1)在可能的情况下,应与社区利益相关者进行有意义的合作,从开始到传播都应以研究为基础; (2)跨性别健康研究的语言和框架不应带有歧视性; (3)研究应传播回社区; (4)跨性别者和性别多样性群体的多样性应得到准确反映和敏感反映; (5)知情同意必须是有意义的,没有强迫或不当影响; (6)保护参与者的机密性至关重要; (7)TGGD未成年人应考虑其他同意程序; (8)研究应与当前反对转化,重新定位或修复疗法的专业标准相一致; (9)内部评级机构应避免这种诱惑,以避免,限制或推迟对该主题的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号